Hepatitis b Trials in London, United Kingdom
Conditions / Hepatitis b / London, United Kingdom
Hepatitis b has been the subject of sustained clinical investigation across multiple research sites.
25 total trials for this combination
Showing top 10 of 25 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03361956 | An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection | COMPLETED | PHASE2 |
| NCT00496158 | Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus | TERMINATED | PHASE3 |
| NCT06537414 | A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT00496002 | Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus | TERMINATED | PHASE3 |
| NCT00065507 | Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation | COMPLETED | PHASE3 |
| NCT02699736 | EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV | ENROLLING_BY_INVITATION | — |
| NCT01163240 | Epidemiological Study in Children and Adolescents With Chronic Hepatitis B | COMPLETED | — |
| NCT06497504 | Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04449029 | A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) | COMPLETED | PHASE2 |
| NCT04954859 | Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) | RECRUITING | PHASE2 |